Jong Seok Lee

593 total citations
18 papers, 478 citations indexed

About

Jong Seok Lee is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Jong Seok Lee has authored 18 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Jong Seok Lee's work include Gastric Cancer Management and Outcomes (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Jong Seok Lee is often cited by papers focused on Gastric Cancer Management and Outcomes (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Jong Seok Lee collaborates with scholars based in South Korea, Ethiopia and Puerto Rico. Jong Seok Lee's co-authors include Keun‐Wook Lee, Soo‐Mee Bang, Jeong‐Ok Lee, Jee Hyun Kim, Mi Jung Kim, Yu Jung Kim, Hye Seung Lee, Sung‐Bum Kang, Duck‐Woo Kim and Kim Js and has published in prestigious journals such as American Journal of Roentgenology, Medicine and Annals of Surgical Oncology.

In The Last Decade

Jong Seok Lee

18 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jong Seok Lee South Korea 12 215 146 108 96 66 18 478
Sonia Yip Australia 14 308 1.4× 361 2.5× 66 0.6× 83 0.9× 84 1.3× 75 662
Ji Hyeon Joo South Korea 13 125 0.6× 151 1.0× 65 0.6× 142 1.5× 24 0.4× 53 463
Todd A. Pezzi United States 15 280 1.3× 271 1.9× 52 0.5× 114 1.2× 34 0.5× 37 566
Deborah Malvi Italy 13 127 0.6× 147 1.0× 31 0.3× 178 1.9× 69 1.0× 54 504
Emilie Bogart France 12 107 0.5× 242 1.7× 39 0.4× 107 1.1× 38 0.6× 35 437
Ewa Chmielowska Poland 12 251 1.2× 132 0.9× 119 1.1× 47 0.5× 109 1.7× 44 468
Virag Dandekar United States 4 234 1.1× 151 1.0× 24 0.2× 168 1.8× 109 1.7× 6 527
Mignon-Denise Keyver-Paik Germany 12 255 1.2× 81 0.6× 33 0.3× 143 1.5× 82 1.2× 30 552
Jacques Cretin France 7 171 0.8× 86 0.6× 41 0.4× 57 0.6× 44 0.7× 9 328
Christophe Zemmour France 13 247 1.1× 141 1.0× 36 0.3× 179 1.9× 147 2.2× 51 575

Countries citing papers authored by Jong Seok Lee

Since Specialization
Citations

This map shows the geographic impact of Jong Seok Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jong Seok Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jong Seok Lee more than expected).

Fields of papers citing papers by Jong Seok Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jong Seok Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jong Seok Lee. The network helps show where Jong Seok Lee may publish in the future.

Co-authorship network of co-authors of Jong Seok Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Jong Seok Lee. A scholar is included among the top collaborators of Jong Seok Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jong Seok Lee. Jong Seok Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kim, Yu Jung, Soyeon Kim, Tae Min Kim, et al.. (2024). A phase II study of osimertinib in patients with NSCLC harboring EGFR exon 20 insertion: A multicenter trial of the Korean Cancer Study Group (LU17-19). Lung Cancer. 194. 107870–107870. 1 indexed citations
2.
Kim, Yeon Joo, Sehoon Choi, Jae Kwang Yun, et al.. (2024). Stereotactic ablative radiotherapy for pulmonary metastasis from sarcoma: a retrospective comparison with metastasectomy. Clinical & Experimental Metastasis. 42(1). 2–2. 1 indexed citations
3.
Kim, Se Hyun, Mi Jung Kim, Yu Jung Kim, et al.. (2017). Paclitaxel as third-line chemotherapy for small cell lung cancer failing both etoposide- and camptothecin-based chemotherapy. Medicine. 96(42). e8176–e8176. 16 indexed citations
4.
Yoo, Shin Hye, Jeong-Han Kim, Gyeong‐Won Lee, et al.. (2017). Nephrotic syndrome associated with metastatic thymoma treated with chemotherapy. Medicine. 96(1). e5408–e5408. 5 indexed citations
5.
Lee, Hyewon, Tak Yun, Eunyoung Lee, et al.. (2017). Prognostic role of the neutrophil-to-lymphocyte ratio in patients with primary central nervous system lymphoma. Oncotarget. 8(43). 74975–74986. 19 indexed citations
6.
Byun, Ja Min, Jeong‐Ok Lee, Beodeul Kang, et al.. (2016). Diffuse Large B-Cell Lymphoma in the Elderly: Real World Outcomes of Immunochemotherapy in Asian Population. Clinical Lymphoma Myeloma & Leukemia. 16(9). 503–510.e3. 9 indexed citations
7.
Lim, Yoojoo, Jeong‐Ok Lee, Se Hyun Kim, et al.. (2015). Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden. Thrombosis Research. 135(5). 846–851. 24 indexed citations
9.
Kim, Jin Won, Se Hyun Kim, Hyun Chang, et al.. (2014). p21-Activated Kinase 4 (PAK4) as a Predictive Marker of Gemcitabine Sensitivity in Pancreatic Cancer Cell Lines. Cancer Research and Treatment. 47(3). 501–508. 32 indexed citations
11.
Kim, Mi Jung, Hye Seung Lee, Jee Hyun Kim, et al.. (2012). Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer. BMC Cancer. 12(1). 347–347. 119 indexed citations
12.
Kim, Ji Yeon, Yu Jung Kim, Keun‐Wook Lee, et al.. (2012). Practical Outcome of Adjuvant FOLFOX4 Chemotherapy in Elderly Patients with Stage III Colon Cancer: Single-center Study in Korea. Japanese Journal of Clinical Oncology. 43(2). 132–138. 9 indexed citations
13.
Shin, Dong‐Yeop, Jeong‐Ok Lee, Myung‐Sook Park, et al.. (2012). Toxicities and functional consequences of systemic chemotherapy in elderly Korean patients with cancer: A prospective cohort study using Comprehensive Geriatric Assessment. Journal of Geriatric Oncology. 3(4). 359–367. 16 indexed citations
14.
Kim, Jee Hyun, Myung‐Sook Park, Keun‐Wook Lee, et al.. (2010). Comprehensive geriatric assessment in Korean elderly cancer patients receiving chemotherapy. Journal of Cancer Research and Clinical Oncology. 137(5). 839–847. 30 indexed citations
15.
Lee, Keun‐Wook, Jongyoun Yi, In Sil Choi, et al.. (2009). Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement. Annals of Hematology. 88(9). 829–838. 14 indexed citations
16.
Lee, Jun Ho, Jong Seok Lee, Keun Won Ryu, et al.. (2007). Abdominal Shape of Gastric Cancer Patients Influences Short-Term Surgical Outcomes. Annals of Surgical Oncology. 14(4). 1288–1294. 66 indexed citations
17.
Choi, Hyuck Jae, Sokbom Kang, Sun Lee, et al.. (2006). MRI for Pretreatment Lymph Node Staging in Uterine Cervical Cancer. American Journal of Roentgenology. 187(5). W538–W543. 75 indexed citations
18.
Lee, Jong Seok, et al.. (1996). Enhanced expression of cathepsin L in metastatic bone tumors. Journal of Korean Medical Science. 11(2). 144–144. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026